Cargando…
Non–Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment
Background. There has been much innovation in the treatment of non–small cell lung cancer (NSCLC) in recent years. In particular, use of immuno-oncology (IO) therapies has been growing. Methods. Patients with NSCLC in the United States were surveyed online using a discrete choice experiment to elici...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249575/ https://www.ncbi.nlm.nih.gov/pubmed/32548305 http://dx.doi.org/10.1177/2381468320922208 |